MiMedx Group Inc. (MDXG) is a regenerative biomaterials company with a patented allograft tissue technology that has application potential in a wide array of healthcare fields. Led by CEO Parker Petit, a legend in the healthcare space who previously sold two companies for billions, and a number of high-level executives from his previous ventures, MiMedx has assembled a management team with the experience and savvy to create another billion dollar market-cap company.
With a $10 billion opportunity in front of it, which could potentially grow into a $15-20 billion opportunity, MiMedx is on a runway which could create exponential growth over the next few years. Although shares of MDXG have already enjoyed nice gains since the...
Only subscribers can access this article, which is part of the PRO research library covering 3,573 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: